Emjard M Xr 12.5mg/1000mg (14 Tablet / Pack)
Once-daily extended-release prescription combination tablet for type 2 diabetes management.
Emjard M Xr 12.5mg/1000mg Tablets are an oral, extended-release prescription combination medicine designed for once-daily type 2 diabetes therapy. It features a controlled-release mechanism that slowly delivers metformin alongside a standard immediate-release SGLT2 inhibitor. This advanced formulation significantly improves gastrointestinal tolerance and compliance while maintaining stable, round-the-clock blood sugar control.
Purpose
Used for sustained, 24-hour glycemic control and cardiovascular risk reduction.
Ingredients
Empagliflozin 12.5mg, Metformin HCl 1000mg (Extended Release)
Warnings
Swallow the extended-release tablet whole; do not crush, chew, or split. Discontinue use if severe hypovolemia or acute kidney injury is suspected. Risk of lactic acidosis accumulation in patients with compromised hepatic function. Not authorized for pediatric populations or type 1 diabetic care.
Side Effects
Transient abdominal discomfort Mild diarrhea or nausea Increased urinary volume Genital mycotic overgrowth
Storage Instructions
Store below 30°C in a dry space away from direct heat.
| Status | Active |
Related Products
Vesun Sunblock Cream Spf60 (60g)
Venlay Skin Brightening Cream (100g)
Venlay Brightening Face Wash (100ml)
Sylic A Serum (20ml)
Sylic A Face Wash (100ml)
Rucid syrup (120ml)
Rivia Anti Dandruff Shampoo (120ml)
